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OBJECTIVES: Diabetes has been increasing worldwide and the treatment of type 2
diabetes is based on lifestylemodification and pharmacological therapy. Appropri-
ate self-care practices including lifestylemodifications andmedication compliance
are critical to satisfactory control andmanage diabetes and to prevent from comor-
bidities. The objective of this studywas to assess current treatment patterns, treat-
ment compliance and reasons for noncompliance for patients with type 2 diabetes
in Pakistan. METHODS: A cross-sectional study was conducted to collect data
through structured interviews based on pre-tested questionnaire. Total 211 pa-
tients including 46% males and 54% females from the ages 25 and over were ran-
domly selected for the study fromapopulation of patients attending 5 primary care
diabetes centers throughout Karachi. Information was collected on socio-demo-
graphic characteristics, diabetes duration and compliance to physician’s advices.
RESULTS: Overall, median age for male subjects was 53 years, significantly older
(p0.008) than females (46 years). The mean duration of diabetes among respon-
dents was 9.23.8 years. Of the total, majority of patients were treated with oral
medication (61%). Only 27% reported full compliance as per physician’s advice for
timelymedication, routine exercise, timely lab investigation and follow up for next
visit. About 45% of the subjects were taking medication for diabetes related com-
plications. Lack of financial resources, knowledge and supportive services and fear
of needle were the main reasons for noncompliance. We also found that people
with low literacy levels were less likely to manage their condition effectively com-
pared to people with higher educational level (p0.001). CONCLUSIONS: To man-
age the diabetes both physicians and patients should attempt to improve compli-
ance, which could lead to better disease management. Based on the findings, a
public health intervention and information campaign is needed to change behav-
iours of persons with diabetes. Further, physicians can also educate patients by
identifying potential risks of non-compliance and educate them accordingly.
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OBJECTIVES: To quantify the influence of methodological assumptions/parame-
ters on the results of prescription-based NA analysis based on 3-years prescription
data (German Statutory Health Insurance Fund) covering 241,537 T2DM patients.
METHODS: With the help of MPRs in an interval-based approach, a NA-base sce-
nario for 25 anti-diabetic active ingredients was calculated for each patient. In a
scenario analysis, the quantitative influence of all in all 9 parameters on the MPR
level was derived. The most important parameter concerned the definition of an
ideal prescription profile (“100%-adherer”). Assumptions simplifying the real pre-
scription behaviour did not allow to accurately reflect the variety of medications
and the clinical need to change medications. Therefore, a total of eight clinically
meaningful prescription profileswere derived assigning patients exclusively by the
use of self-developed algorithms. For each patient a MPR estimated by standard
methodology (base case)was comparedwith theMPR based on our novel approach.
RESULTS: In the base case, the average MPR resulting from the analysed active
ingredient combinations was 80.76%. A total of 62.85% of patients had an
MPR80%. According to the novel prescription profiles, patients were distrib-
uted as follows: 59.9% Mono-medication, 12.9% Single-Drug Switcher, 11.3%
Single-Drug Add-on, 2.0% Multiple-Drug Add-on, 5.0% Polytherapy consistent,
2.5% Polytherapy Add-on, 3.5% Polytherapy Drop-off, and 1.3% Polytherapy
Switcher. A total of 1.6% of the patients could not unequivocally be assigned to
one of the categories. Comparing a base-case MPR analysis with our novel ap-
proach resulted in MPR deviations in specific patient groups of up to 27.4 per-
centage points. CONCLUSIONS: Probably the biggest challenge in NA analysis
based on prescription data is to differentiate between physician-induced and pa-
tient-induced medication changes. The first should be reflected in the adequate
profile of an NA analysis and should not be misinterpreted as NA itself. The meth-
odology described presents a powerful alternative for defining clinically meaning-
ful prescription patterns.
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OBJECTIVES: The burden of diabetic peripheral neuropathic pain (DPNP) on pa-
tients’ lives is poorly understood and insufficiently measured with current instru-
ments. Proper assessment of DPNP impact on patients’ lives is critical to accurately
determine treatment efficacy. METHODS: 45 blinded, semi-structured telephone
interviews were conducted to assess the impact of DPNP on functioning and pa-
tient well-being enrolled in a randomized, double-blind, placebo-controlled study.
Interviews were taped, transcribed, coded, and analyzed according to grounded
theory principles. RESULTS: Patients were 31%female, 53% white and the average
agewas 56 years. Twomajor domains of burdenwere identified: physical function-
ing and daily life. Physical functioning was affected in 36 (80%) patients whose
DPNP led to difficulty in walking, 33 (73%) reported low energy levels, and 32 (71%)
noted a diminished ability to exercise. Twenty-five (55%) patients reported difficul-
ties with bending, 22 (49%) difficulty standing, 20 (44%) reduced ease of movement,
19 (42%) had problems with balance and 16 (36%) in climbing stairs. DPNP affected
sleep in 37 (82%) patients who reported awakening in the night, 28 (62%) had diffi-
culty falling asleep, 16 (36%) couldn’t fall back asleep once awakened; and 36 (80%)
patients rarely felt rested during the day. Daily life was affected in 34 (76%) patients
leading to reduced productivity, 30 (67%) reported that DPNP reduced their enjoy-
ment of life, and 26 (58%) found that DPNP limited their recreational activities.
Twenty-four (53%) of patients had a reduced ability to focus on tasks due to pain, 22
(49%) reported that DPNP limited their ability to work, 20 (44%) experienced diffi-
culty in accomplishing routine household chores, and 17 (38%) had reduced
independence. CONCLUSIONS: DPNP causes significant burden on patient’s phys-
ical functioning and daily life. PROmeasures used to determine treatment efficacy
should assess these impacts to accurately reflect the patient’s perspective.
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OBJECTIVES: Diabetic Peripheral Neuropathic Pain (DPNP) is a poorly understood
complication of diabetes that has serious consequences for patients’ physical func-
tioning and daily activities. Awell-developed patient-reported outcome (PRO)mea-
sure that can assess the impact of DPNP on function and that is sensitive to change
would facilitate research important to patients. The purpose of the study was to
develop a measure of key impacts important to patients with DPNP. METHODS:
Diabetic Peripheral Neuropathic Pain (DPNP) is a poorly understood complication of
diabetes that has serious consequences for patients’ physical functioning and daily
activities. A well-developed patient-reported outcome (PRO) measure that can as-
sess the impact of DPNP on function and that is sensitive to changewould facilitate
research important to patients. The purpose of the studywas to develop ameasure
of key impacts important to patients with DPNP. RESULTS: Saturation of concepts
was reached after 3 focus groups and telephone interviews with a total of 25 DPNP
patients (demographics: average age 52 years old, 68% male, 60% White). The av-
erage duration of DPNPwas 5 years (range 1-20 years) and the average self-reported
pain score (scale 0-10) was 6.9 (range 4-10). The theoretical framework described
two domains of impact: Physical Functioning and Daily Functioning. Based on the
results of the cognitive debriefing a 27-item, validation ready version of the mea-
sure with 4 domains (Physical Functioning–Sleep, Physical Functioning-Mobility,
Daily Functioning- Daily Activities and Daily Functioning-Relationships) was
generated. CONCLUSIONS: The Diabetic Peripheral Neuropathic Pain Impact Mea-
sure is believed to accurately capture relevant DPNP patients’ experiences as it
relates to their ability to function. Data generated from the measure should assist
clinicians in assessing key impacts in patientswithDPNP, facilitate development of
targeted treatments and provide a meaningful measurement of treatment effect.
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OBJECTIVES: Lack of access to healthcare for patients with diabetes has been as-
sociatedwith lower self-reported health-related quality of life (HRQOL), whichmay
lead to significant economic burden. The objective of the study was to determine
the impact of healthcare access on HRQOL of patients with diabetes. METHODS:
The 2009 Behavioral Risk Factor Surveillance System (BRFSS), a national health
telephone survey administered by the Centers for Disease Control and Prevention
(CDC), was analyzed. It included questions on patient demographics and health-
related perceptions, conditions, and behaviors. HRQOL was defined as the number
of unhealthy days, a sum of physical and mental unhealthy days in the past one
month. Healthcare access was defined by whether the patient had healthcare cov-
erage, had a healthcare professional or could not see a doctor because of cost.
Descriptive analysis includedmeans, standard errors and relevant T-tests. Poisson
regression was performed to measure the impact of healthcare access variables,
age, race, gender,marital status andmedian household income onunhealthy days.
RESULTS: In 2009, from 5.2 million diabetic patients, 0.7 million (14%) did not have
healthcare coverage, 0.48 million (9%) did not have healthcare professional and
1.54 million (30%) could not see a doctor due to cost. The average number of un-
healthy days in a month, for diabetic patients with healthcare coverage was lower
than those without (22 days versus 23 days, p-value0.01); for those who could see
a doctor due to cost was lower than those who could not (22 days versus 24 days,
p0.01); was the same for those with or without a healthcare professional. Regres-
sion results showed, not having healthcare coverage and healthcare professional,
each significantly (p-value0.01) increased an excess unhealthy day in diabetic
patients. CONCLUSIONS: Lack of healthcare access negatively impacts HRQOL.
Measures are needed to ensure adequate healthcare access in diabetic patients.
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OBJECTIVES: To assess the quality of life (QoL) of Taiwanese type 2 diabetes pa-
tients, we have conducted feasibility studies applying different QoL utility scores.
This study aims to explore the adaptation and feasibility of time-trade-off (TTO)
method for measuring QoL in Taiwanese diabetic outpatients. METHODS: This
cross-sectional study was conducted from June to December 2010 at nephrology
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